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	All chemicals were obtained commercially. (4-ClC6H4)3B3O3 was obtained by dehydration (oven 100 oC, 24h) of the commercially available boronic acid, 4-ClC6H4B(OH)2.  NMR spectra were obtained on a Bruker Avance-400 spectrometer with 1H, 11B, 13C, and 31P spectra (CDCl3 unless stated otherwise) obtained at 400, 128, 101, and 162 MHz, respectively.  NMR data are reported in ppm with positive chemicals shifts () to high frequency (downfield) of TMS (1H, 13C), BF3.OEt2 (11B) and H3PO4 (31P).  Infra-Red spectra were obtained as KBr pellets on a Perkin-Elmer FTIR spectrometer over 450-4000 cm-1. TGA and DSC analysis was performed (in air) between 10 and 800 oC on a SDT Q600 V.4.1 Build 59 instrument using Al2O3 crucibles, with a ramp rate of 10 oC per minute. Powder XRD data were obtained on a Philips 1050/37 X-ray diffractometer equipped with an iron filter, using Cu-K radiation ( = 0.154056 nm) with a continuous scan between 2  = 5o-75o and Philips X’Pert software.  CHN analysis was carried out at OEA Laboratories Ltd, Callington, Cornwall. Single crystal X-ray crystallography was carried out at the EPSRC National Crystallographic Service at the University of Southampton.

2.2 Preparation of triarylboroxine.amine adducts. 
	The triarylboroxine.amine adducts were all prepared using a general procedure [10], as detailed in Section 2.2.1 for compound 1a.

2.2.1 Preparation of tri(4-chlorophenyl)boroxine.morpholine, CPB.C4H9NO (1a).
	Morpholine (0.11g, 1.25 mmol) was added to a stirred suspension of (4-ClC6H4)3B3O3 (0.50 g, 1.20 mmol) in Et2O (20 ml), under an dry N2 atmosphere. After the solid dissolved (approximately 10 minutes) the solution was filtered and the solvent removed under vacuum. The resulting white solid product was recrystallized from CHCl3 (0.55 g, 92% yield). Mp: 217 – 220 °C. Elemental Anal. Calc. (%) for C22H21B3Cl3NO4: C, 52.6; H, 4.2; N, 2.8. Found (%): C, 52.4; H, 4.3; N, 2.8. NMR (CDCl3, RT). 1H /ppm: 3.05-3.12 (br m, 5H), 3.78 (br s, 4H), 7.37 (d, 6H), 7.90 (d, 6H). 13C /ppm: 44.43 (2CH2), 66.09 (2CH2), 128.04 (6CH), 135.44 (6CH). 11B /ppm: 21.0. IR (KBr disk) νmax/cm-1: 3437 (br), 3214 (vs), 3070, 3026, 2982, 2854 (m), 1591 (vs), 1484 (s), 1433 (s), 1410 (s), 1374 (m), 1326 (s), 1280 (s), 1248 (m), 1191 (s), 1125 (s), 1088 (s), 1044 (m), 1012 (s), 889 (m), 848 (m), 812 (s), 766 (s), 727 (m), 664 (s), 624, 538, 452 (s). p-XRD: d spacing/Å (% rel. int.): 5.43 (100), 3.45 (95), 3.63 (77), 3.82 (68), 5.36 (54), 5.47 (53). 

2.2.2 Preparation of tri(4-chlorophenyl)boroxine.benzylamine, CPB.C7H9N (1b).  
	0.61 g, 98% yield. Mp: 155 – 157 °C. Elemental Anal. Calc. (%) for C25H21B3Cl3NO3: C, 57.5; H, 4.1; N, 2.7. Found (%): C, 57.1; H, 4.1; N, 2.7. NMR (CDCl3, RT). 1H /ppm: 3.72 (s, br, NH2), 3.93 (s, 2H, CH2), 7.18 (m, 2H), 7.34 – 7.41 (m, 9H), 7.94 (d, 6H). 13C /ppm: 45.11 (CH2), 128.08 (CH), 128.19 (CH), 129.15 (CH), 135.23 (CH), 136.26 (C).  11B /ppm:  19.8. IR (KBr disk) νmax/cm-1: 3434 (br), 3274 (s), 3205 (s, br), 3219 (s, br), 3067 (s), 3033 (s), 1920 (s), 1593 (vs, br), 1402 (s), 1376 (s), 1344 (s), 1324 (s), 1289 (s, br), 1243 (s), 1206 (m), 1115 (s), 1083 (s, br), 1050 (m), 1014 (s), 992 (s), 958, 938, 916, 881 (m, br), 822 (s, br), 775 (s), 732 (s), 700 (s), 669 (s), 628, 604, 541 (m), 522 (m), 480 (m), 453 (s). p-XRD: d spacing/Å (% rel. int.): 3.98 (100), 3.38 (92), 4.69 (58) 2.03 (69). 

2.2.3 Preparation of tri(4-chlorophenyl)boroxine.cyclohexylamine, CPB.C6H13N (1c). 
	0.51 g, 89% yield. Mp: 177 – 181 °C. Elemental Anal. Calc. (%) for C24H25B3Cl3NO3: C, 56.1; H, 4.9; N, 2.7. Found (%): C, 54.7; H, 4.8; N, 2.5. NMR (CDCl3, RT).  1H /ppm: 1.09-1.26 (m, 5H), 1.59 (d, 1H), 1.70 (d, 2H), 1.98 (d, 2H), 2.97 (m, 1H), 3.55 (br s, 2H), 7.38 (d, 6H), 7.90 (d, 6H).  13C /ppm: 24.31 (2CH2), 24.91 (CH2), 33.50 (2CH2), 51.22 (C), 128.04 (6CH), 135.20 (6CH), 136.21 (C-Cl). 11B /ppm: 22.2. IR (KBr disk) νmax/cm-1: 3436 (br), 3275 (m), 3233 (m), 3072 (w), 2935 (s, br), 2858 (s), 1592 (s), 1562 (m), 1434 (m), 1408 (s), 1376 (m), 1339 (m), 1327 (m), 1285 (s, br), 1243 (m), 1189 (m), 1120 (m), 1081 (s), 1013 (s), 982 (m), 821 (s), 765 (s, br), 733 (m), 662 (m), 582, 451 (s). p-XRD: d spacing/Å (% rel. int.): 3.48 (100), 4.72 (78), 4.12 (55), 4.01 (48), 4.40 (47), 4.89 (44).

2.2.4 Preparation of tri(4-chlorophenyl)boroxine.2-picoline CPB.C6H7N (1d). 
	0.44 g, 72% yield. Mp: 289 – 291 °C. Elemental Anal. Calc. (%) C24H19B3Cl3NO3: C, 56.7; H, 3.8; N, 2.8. Found (%): C, 56.2; H, 3.8; N, 2.2. NMR (CDCl3, RT). 1H /ppm: 2.75 (s, 3H, CH3), 7.30 (d, 1H), 7.38 (m, 7H), 7.81 (t, 1H), 7.92 (d, 6H), 9.07 (d, 1H). 13C /ppm: 23.56 (CH3), 122.13 (CH), 126.84 (CH), 128.15 (CH), 135.80 (CH), 136.97 (C-Cl), 139.44 (CH), 146.19 (CH), 157.94 (C). 11B /ppm: 23.4. IR (KBr disk) νmax/cm-1: 3436 (br), 3071, 3035, 2940, 1620 (m), 1594 (s), 1563 (m), 1485 (m), 1406 (s, br), 1374 (m, br), 1344 (s, br), 1327 (s, br), 1294 (s, br), 1283 (s, br), 1121 (s), 1082 (s, br), 1043 (m, br), 1014 (s), 977 (m), 822 (m), 808 (m), 760 (s, br), 740 (s, br), 694 (m), 613 (s), 457 (s). p-XRD: d spacing/Å (% rel. int.): 5.47 (100), 3.63 (61), 3.49 (53), 11.12 (49), 3.70 (39), 5.27 (35). 

2.2.5 Preparation of tri(4-chlorophenyl)boroxine.4-picoline, CPB.C6H7N (1e). 
	0.59 g, 97% yield. Mp: 192 – 195 °C. Elemental Anal. Calc. (%) C24H19B3Cl3NO3: C, 56.7; H, 3.8; N, 2.8. Found (%): C, 56.7; H, 3.7; N, 2.7.  NMR (CDCl3, RT). 1H /ppm: 2.50 (s, 3H, CH3), 7.35 (d, 6H), 7.42 (d, 2H), 7.93 (d, 6H), 8.80 (d, 2H). 13C /ppm:  21.72 (CH3), 126.61 (CH), 127.94 (CH), 135.14 (CH), 143.03 (CH).  11B /ppm:  19.9. IR (KBr disk) νmax/cm-1: 3434 (br), 3072, 3029, 1633 (m), 1593 (s, br), 1563 (m), 1485 (m), 1433 (s, br), 1407 (s, br), 1378 (m, br), 1325 (s, br), 1278 (s), 1246 (s), 1206 (s), 1179 (m), 1118 (m), 1081 (s, br), 1043 (m), 1014 (s), 984 (s), 854 (m), 822 (m), 803 (m), 762 (s, br), 743, 732, 696 (m), 660 (m), 636 (m), 508 (m), 453 (s). p-XRD: d spacing/Å (% rel. int.): 4.62 (100), 5.39 (78), 3.46 (56), 3.58 (44), 4.97 (36), 3.25 (27).
 
2.2.6 Preparation of tri(4-chlorophenyl)boroxine.piperidine, CPB.C5H11N (1f). 
	0.59 g, 98% yield. Mp: 127 – 130 °C. Elemental Anal. Calc. (%) for C23H23B3Cl3NO3: C, 55.2; H, 4.6; N, 2.8. Found (%): C, 55.1; H, 4.6; N, 2.8. NMR (CDCl3, RT). 1H /ppm: 1.66 (s, br, 6H), 2.80 (s, br, 5H), 7.37 (d, 6H), 7.91 (d, 6H).  13C /ppm:  23.05 (CH2), 25.37 (CH2), 127.90 (CH), 135.44 (CH). δB (ppm):24.6.IR (KBr disk) νmax/cm-1: 3520 (br), 3223 (vs), 3069 (m), 3026, 2956 (m, br), 2870 (m), 1912, 1591 (vs), 1484 (s), 1435 (s, br), 1410 (s, br), 1376 (m, br), 1326 (s, br), 1282 (s, br), 1246 (s, br), 1188 (s), 1121 (s), 1085 (s, br), 1044 (m), 1012 (s), 971 (m), 868 (m), 810 (s), 766 (s, br), 728 (m), 662 (s), 614 (m), 512, 477, 450 (s). p-XRD: d spacing/Å (% rel. int.): 3.54 (100), 3.55 (70), 3.67 (39), 3.68 (39), 3.95 (34), 3.18 (30).

2.2.7 Preparation of bis(tri(4-chlorophenyl)boroxine).4,4’-trimethylenedipiperidine, (CPB)2.C13H26N2 (1g). 
	1.72 g, 92 % yield. Mp: 247 – 250 °C. Elemental Anal. Calc. (%) for C31H38B3Cl3N2O3: C, 56.6; H, 4.8; N, 2.7. Found (%): C, 56.3; H, 4.8; N, 2.6. NMR (CDCl3, RT). 1H /ppm: 1.06-1.23 (m, 10H), 1.35 (br s, 2H), 1.82 (d, 4H), 2.55 (br s, 4H), 2.75 (br s, 2H), 3.38 (br s, 4H), 7.36 (d, 12H), 7.88 (br s, 12H). 13C /ppm:  23.28, 31.56, 34.45, 36.19, 45.14. 11B /ppm: not obtained. IR (KBr disk) νmax/cm-1: 3415 (br), 3229 (m), 3072 (m), 3031 (m), 2928 (m), 2856 (m), 1592 (vs), 1562 (s),  1486 (s), 1435 (s), 1415 (s), 1380 (m), 1330 (m), 1278 (s), 1247 (m), 1196 (s), 1172 (s), 1120 (s), 1097 (s), 1083 (s), 1044 (s), 1014 (vs), 985 (m), 972 (m), 857(m), 828 (m), 816 (m), 769 (s), 733 (m), 670 (m), 663, 629, 612. p-XRD: d spacing/Å (% rel. int.): amorphous solid. 

2.3 Lewis acidity measurements of triarylboroxines. 
	The Et3PO (TEPO) adduct of  tri(4-chlorophenyl)boroxine, CPB.TEPO, was prepared in situ in an NMR tube by the addition of a slight excess of CPB to TEPO dissolved in CDCl3 (0.5 mL). NMR (CDCl3, RT). 1H /ppm: 1.15 – 1.23 (m, 9H, 3CH3), 1.78 – 1.87 (m, 6H, 3CH2), 7.35 – 7.47 (m, 6H, 6CH), 7.76 – 8.10 (m, 6H, 6CH).  13C /ppm: 5.66 (d, 2J = 4.7 Hz, CH3), 18.96 (d, 1J = 67.6 Hz, CH2), 128.45 (CH arom.), 136.77 (CH arom.).  11B /ppm:  29.1. 31P /ppm: 62.0 (AN = 46). 

2.4 Preparation of [C6H11NMe3][Ph4B3O3] (2) 
	[C6H11NMe3]I (2.16 g, 8.01 mmol) was dissolved in water (50 ml) and the Dowex 550Å monosphere resin (OH- form) was added to the solution which was stirred for 48 h. The resin was removed by filtration and the solvent was removed from the filtrate by rotary evaporation to give an oil. The oil was made up to 100 ml in a 1:1 methanol/water solution and  an aliquot of this solution (25 ml, containing 2 mmol) was reacted with PhB(OH)2 (0.47g, 3.86 mmol) and Ph2BOBPh2  (0.34 g, 0.98 mmol). The solvent was then removed (via rotary evaporation/suction filtration) to yield the product, [C6H11NMe3][Ph4B3O3] (2), as a white powder (0.77g, 75%) . M.p. 220 - 225°C. Elemental Anal. Calc. for C33H20B3O3N: C, 74.6; H, 7.6; N, 2.6. Found: C, 74.5; H, 7.6; N, 2.6. NMR (acetone-d6, RT): 1H /ppm: 1.18 (q, 1H), 1.35 (q, 2H), 1.52 (q, 2H), 1.63 (d, 1H), 1.92 (d, 2H), 2.28 (d, 2H)  3.15 (s, 9H), 3.37 (t, 1H), 6.80 (t, 2H), 7.05 (t, 4H), 7.30 (m, 6H), 7.75 (d, 4H), 8.22 (m, 2H).  13C /ppm:  24.35, 25.06, 25.93, 50.56, 75.25, 123.15, 125.75, 126.88, 129.08, 131.72, 134.59. 11B /ppm:  3.4 (1B), 26.9 (2B). IR (KBr disk) νmax/cm-1: 3068 (w), 3012 (w),  2859 (w), 1598 (m), 1469 (m), 1448 (vs), 1421 (s), 1355 (m), 1274 (m), 1231 (vs), 1162 (m), 1145 (m), 1110 (m), 1064 (m), 1025 (m), 953 (m), 867 (m), 770 (m), 751 (m), 702 (vs), 676 (s),  620 (m), 572 (s).  TGA: oxidation of organics to leave 1.5B2O3 (220-390 oC): residue 20.1%  (calc 19.7%). The crude product was recrystallized from acetone to give small (colourless) crystals suitable for an XRD analysis.

2.5 XRD analysis of 1a, 1b, and  2.
	XRD data Crystallographic data for compounds 1a, 1b and 2 are given in Table 1. The crystallographic data collection of compounds were performed on either  a Rigaku AFC12 goniometer equipped with an enhanced sensitivity HG Saturn 724+ detector mounted at the window on an FR-E+ SuperBright molybdenum rotating anode generator with either HF Varimax optics (compound 1a) or VHF Varimax optics (compound 1b) or a Rigaku 007-HF copper rotating anode with AFC11 goniometer with Saturn944+ CCD area detector (compound 2) all at 100(2) K. Cell determinations and data collections were carried out using CrystalClear [25]. With the data reduction, cell refinement and absorption correction using CrysAlisPro [26]. Using Olex2 [27]  the structures were solved using SHELXT [28] and models refined with SHELXL [29]. H1 in 1a was allowed to freely refine as it is involved in hydrogen bonding and all other hydrogen atoms were refined in riding positions.


Table 1.  Crystal data and structure refinement for compounds 1a, 1b, and 2.


Compound 	          1a 	           1b	          2
   			
Empirical formula 	C22H21B3Cl3NO4	C25H21B3Cl3NO3	C33H40B3NO3
Formula weight 	502.18	522.21	531.09
Temperature 	100(2) K	100(2) K	100(2) K
Wavelength 	0.71075 Å	0.71075 Å	1.54187 Å
Crystal system 	Triclinic	Triclinic	Orthorhombic
Space group 	P1 	P1	Pca21
Unit cell dimensions	a = 8.8330(2) Å	a = 10.8662(3) Å	a = 34.3666(1) Å
	b = 11.7778(2) Å	b = 11.6419(4) Å	b = 19.9735(1) Å
	c = 12.3245(3) Å	c  = 21.0508(4) Å	c = 17.2662(1) Å
	 = 81.153(2)°	 = 88.316(2)°	 = 90°
	 = 76.271(2)°	 = 89.333(2)°	 = 90°
	  = 68.541(2)°	  = 70.864(2)°	  = 90°
Volume	1156.00(5) Å3	2514.75(12) Å3	11851.89(10) Å3
Z	2	4	16
Density (calculated)	1.443 Mg / m3	1.379 Mg / m3	1.191 Mg / m3
Absorption coefficient	0.427 mm1	0.393 mm1	0.567 mm1
F(000)	516	1072	4544
Crystal	Block; Colourless	Lath; Colourless	Plate; Colourless
Crystal size	0.130  0.080  0.050 mm3	0.170  0.040  0.010 mm3	0.48  0.40  0.04 mm3
Reflections collected	20528	32418	85957
Independent reflections	5284 [Rint = 0.0220]	11479 [Rint = 0.0236]	18721 [Rint = 0.0231]
Data / restraints / parameters	5284 / 0 / 302	11479 / 0 / 631	18721 / 1 / 1454
Goodness-of-fit on F2	1.040	1.023	1.079
Final R indices [F2 > 2(F2)]	R1 = 0.0288, wR2 = 0.0754	R1 = 0.0461, wR2 = 0.1108	R1 = 0.0321, wR2 = 0.0810
R indices (all data)	R1 = 0.0324, wR2 = 0.0775	R1 = 0.0613, wR2 = 0.1192	R1 = 0.0333, wR2 = 0.0819
Absolute structure parameter	n/a	n/a	0.03(4)
Largest diff. peak and hole	0.405 and 0.225 e Å3	1.467 and 0.877 e Å3	0.410 and 0.199 e Å3


3.  Results and discussion
3.1 Formation of amine complexes of tri(4-chlorophenyl)boroxine
	One to one amine adducts of tri(4-chlorophenyl)boroxine (CPB) were readily prepared by the direct interaction of the organic base with a suspension of the boroxine in Et2O (Scheme 1). The CPB is insoluble Et2O, but the suspension readily dissolved upon addition of amines to form pale yellow solutions of the products, which were isolated in high yields after removal of the solvent and recrystallization of the residue. Six adducts, formulated as PCB.L {L = morpholine (1a), benzylamine (1b), cyclohexylamine (1c), 2-picoline (1d), 4-picoline (1e), piperidine (1f)} based on elemental analysis data, spectroscopic analysis (NMR) and from single crystal XRD studies on representative samples (1a, 1b), were prepared. The IR spectra of compounds 1a-1f all show strong very strong bands in the region 1500-1200 cm-1 assigned to B-O stretches of the boroxole ring [3, 9, 30]. The X-ray structures of 1a and 1b (Section 3.2) clearly demonstrate that they are 1:1 adducts and that the amine ligands are coordinated to one the three boron centres of the CPB rings.








     (4-ClC6H4)3B3O3 + L     → 	(4-ClC6H4)3B3O3.L  (1a-f)
						{L = morpholine (1a), benzylamine (1b),
						cyclohexylamine (1c), 2-picoline (1d), 
						4-picoline (1e), piperidine (1f)}

    2(4-ClC6H4)3B3O3 + L   → 	{(4-ClC6H4)3B3O3}2.L  (1g)
			       			{L = 4,4’-trimethylenedipiperidine}

			                         Scheme 1


3.2 XRD structural studies on tri(4-chlorophenyl)boroxine.morpholine (1a) and tri(4-chlorophenyl)boroxine.benzylamine (1b).  









Figure 3. Drawing of one of the two independent molecules in the solid-state structure of tri(4-chlorophenyl)boroxine.benzylamime (1b), showing selected labelling. Distances (Å): B1-O1, 1.450(3); O1-B2, 1.352(3); B2-O2, 1.390(3); O2-B3, 1.386(3); B3-O3, 1.362(3); O3-B1, 1.458(2); B1-N1, 1.683(3); B1-C1, 1.608(3); B2-C7, 1.568(3); B3-C13, 1.563(3).

3.3 Variable temperature 1H NMR studies on the ligand dissociation/recombination process. 




Figure 4. Variable temperature 1H NMR signals of the aryl substituents on tri(4-chlorophenyl)boroxine in 1g.

	At -10 °C the aryl rings protons of 1g  appear as four separate signals at 7.29, 7.39, 7.65 and 8.00 ppm, with the relative intensities 8:4:8:4 and consistent with slow ligand exchange relative to the NMR timescale. Upon warming, the two upfield signals (associated with protons which are at the meta to the boron atoms) broaden, coalesce at -5 °C, and then sharpen into a doublet at 7.37 ppm. Likewise, the two lower-field signals (associated with protons at the ortho to the boron atoms) broaden, coalesce at +5 °C, and then sharpen into a broad singlet upon warming. The Gibbs free energy of activation (ΔG‡) for a 1:1 ligand exchange process can be calculated [37] from the ligand-exchange rate (k) at coalescence temperature (Tc) and the low temperature peak separation at slow-exchange (δv). This approach is strictly only correct for a 1:1 site exchange [12] although can give useful approximations for 2:1 systems.  The calculated ΔG‡ data for 1a, 1e, 1f and 1g can be found in Table 2. Data was not available for 1d since slow exchange was not observed in the 1H NMR spectra at -35 °C. The ΔG‡ values obtained for these CPB.amine complexes lie in the range of 49-58 kJmol-1.  These data are at the high end of ranges reported for ligand exchange for various N-donor ligands at tri(3,5-dimethylphenyl)boroxine (MXB, 45-49 kJmol-1 [10]), tri(4-methylphenyl)boroxine (PTB, 43-46 kJmol-1 [10] ), tri(2-methylphenyl)boroxine (OTB, 43-49 kJmol-1 [7]), tri(4-nitrophenyl)boroxine (MNB, 50 kJmol-1 [8]) and tri(4-bromophenyl)boroxine (PBB, 39-54 kJmol-1 [8 ]). Comparative data are available for morpholine as a ligand in 1a for boroxines PBB, PTB and MXB; the activation energy for morpholine.PCB is calculated to be the highest, by 2-5 kJmol-1. Likewise, data for 1e can be directly compared with that for 4-picoline.OTB and 1e is higher by 5 kJ mol-1.  However, these differences are likely to be within experimental error and may not indicate possible trends. 






















Table 2.  Variable temperature 1H NMR data. a k = 2-1/2πδν. bΔG‡ = -RTln(khkB-1T-1). c From upfield aromatic doublet of (4-ClC6H4)3B3O3.L. d From downfield aromatic doublet of (4-ClC6H4)3B3O3.L.


3.4 Measurement of Lewis acidity of (4-ClC6H4)3B3O3 
	Gutmann’s Acceptor numbers (AN) are generally accepted as useful way to assess the relative Lewis acidity of solvents [38, 39]. The AN of a particular solvent is calculated from 31P{1H} NMR chemical shifts of triethylphosphine oxide (TEPO) dissolved in that solvent. This scale has two fixed points, with the weak Lewis acid hexane at zero, and the strong Lewis acid antimony pentachloride at 100.  A modification of this procedure, involving the synthesis of Et3PO adducts of Lewis acids (often in situ), enables the acidity of the Lewis acid to be determined by a 31P NMR measurement [40-42]. The Et3PO adduct of CPB proved difficult to isolate following the synthetic procedures used above but nevertheless was prepared in in situ. The 31P NMR shift of CPB.Et3PO (62.0 ppm) gave an AN number of 46, indicative of moderate Lewis acidity.  This value slightly extends the AN range (49-51) reported for the triorganoboroxines Ph3B3O3, (4-BrC6H4)B3O3 and Me3B3O3 [9] and demonstrates that the 4-chlorophenyl groups have little effect on the Lewis acidity of the triarylboroxine. The CPB is a considerably weaker Lewis acid than the perfluorinated derivatives (C6F5)3B3O3 (AN = 86) and (C6F5)3B (AN = 82), which contain the strongly electron withdrawing pentafluorophenyl groups [42-44].
	
3.5 Synthesis of and XRD studies on trimethyl(cyclohexyl)ammonium tetraphenylboroxinate (2). 
	The tetraryltriboroxinate(1-)  anion is isoelectronic with Lewis base adducts of triarylboroxines, Ar3B3O3.L. Whilst there are many reported crystal structures of Lewis base adducts of boroxines, structures containing tetraryltriboxinate(1-) anions are much rarer and are limited to the following few examples: [NMe4][Ph4B3O3]  [33], [(tBu3PAu)4P][Ph4B3O3] [34],  [Me3NCH2CH2OH][Ph3B3O3] [35], and [Ph2B{OCH2NMe(CH2)n}2][Ph4B3O3] (n = 4, 5) [36]. [(tBu3PAu)4P][Ph4B3O3] was prepared serendipitously, whereas the other salts were all prepared by the procedure first described by Rittig and co-workers [33].  Herein we report the synthesis of one further example in a salt containing the trimethyl(cyclohexyl)ammonium cation and report on its solid-state structure. 
	[C6H11NMe3][Ph4B3O3]  (2) was prepared in high yield following the method of Rittig and co-workers from Ph2BOBPh2, PhB(OH)2 and [C6H11NMe3][OH] in a 1:4:2 ratio in MeOH/H2O solution [33]. Compound 2 was characterized by satisfactory elemental analysis data, IR and NMR (1H, 11B, 13C) spectroscopy, thermal analysis (TGA/DSC) and a single-crystal XRD study. 
	NMR spectra (room temperature) for 2 were recorded in d6-acetone and 1H and 13C spectra were fully consistent with  the anion and cation present.  In particular, and in contrast to 1a-1g, the 11B spectrum of 2 showed two peaks, of relative intensity 2:1 and at chemical shifts expected for three-coordinate {O2BC} and four-coordinate {O2BC2} centres [45]. 
	The thermal properties of 2 were determined by TGA/DSC analysis in air over the temperature range of 25-800°C (see Supplementary Information). The salt decomposed in a single-stage process (220-390 °C) by oxidation (exothermic) of the organics present with the formation of B2O3.  Oxidation of organics to leave B2O3 is always observed in the thermolysis of organic cation polyborates [46]. At the start of this decomposition process there is a small endothermic peak (230 oC) in the DSC trace and this corresponds to the sample’s melting point. 




Figure 5. Drawing of one of the four independent cations and anions in the solid-state structure of trimethy(cyclohexyl)ammonium tetraphenylboroxinate(1-) (2), showing selected labelling. Distances (Å): B1-O1, 1.510(3); O1-B2, 1.332(3); B2-O2, 1.394(3); O2-B3, 1.399(3); B3-O3, 1.339(3); O3-B1, 1.500(3); B1-C1, 1.628(4); B1-C7, 1.630(3); B2-C13, 1.578(3); B3-C19, 1.569(3), N131-C131, 1.553(3), N131-C137, 1.498(3); N131-C138, 1.503(3); N131-C139, 1.498(3).







Figure 6. The resonance structure on the left makes an important contribution to the boroxole ring bonding in the tetraphenylboroxinate(1-) (Ar =Ph; L =  Ph-)  anion in 2 
and to the amine adducts of tri(4-chlorophenyl)boroxine, 1a and 1b.

4. Conclusions
	A number of adducts of N-donor adducts of tri(4-chlorophenyl)boroxine (PCB) have been prepared and two examples (PCB.L, L = morpholine, cyclohexylamine), together with a tetraphenylboroxinate(1-) salt have been characterized crystallographically. These structures shown a variation of ring BO bond-lengths of the boroxole ring consistent with -bonding between the oxygen atoms adjacent to the four-coordinate boron and the other two boron atoms.  In solution, ligand dissociation / recombination occurs and this has been followed by variable temperature NMR spectroscopy.  The experimentally determined ΔG‡ values obtained for these CPB.amine complexes lie in the range of 49-58 kJmol-1, and although these data are at the high end of ranges reported for ligand exchange for other triarylboroxine adducts, such differences may be within experimental error and may not have significance. 
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